Health
Potency-enhancing drugs show ability to improve prognosis in patients with colorectal cancer – News-Medical.Net
A new study from Lund University and Region Skåne in Sweden indicates that potency-enhancing PDE5 inhibitor drugs have an anti-cancer potential with the ability to improve the prognosis in patients with colorectal cancer.
A new study from Lund University and Region Skåne in Sweden indicates that potency-enhancing PDE5 inhibitor drugs have an anti-cancer potential with the ability to improve the prognosis in patients with colorectal cancer. PDE5 inhibitors include a few approved drugs in which sildenafil (Viagra) is the most well-known. The article is published in Nature Communications.
Available preclinical evidence suggests that PDE5 inhibitors could slow down the tumor growth and progression in mice, but it is…
-
General24 hours agoUK names Sarah Mullally as first female Archbishop of Canterbury to lead Church of England
-
General24 hours agoSussan Ley responds to Andrew Hastie’s Shadow Cabinet resignation
-
General22 hours agoa pivotal moment in Liberal power struggle
-
Noosa News22 hours agoTayla Harris stars as Melbourne defeats Essendon by 14 points